Home

menetrend precedens Viszonylag ipi prognostic index szolgáltatás Laza Szobor

KoreaMed
KoreaMed

International Prognostic Index: Agressive Non-Hodgkin's Lymphoma
International Prognostic Index: Agressive Non-Hodgkin's Lymphoma

The revised International Prognostic Index (R-IPI) is a better predictor of  outcome than the standard IPI for patients with diffuse large B-cell  lymphoma. - ppt download
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma. - ppt download

The International Prognostic Index (IPI) [117] and age-adjusted IPI... |  Download Table
The International Prognostic Index (IPI) [117] and age-adjusted IPI... | Download Table

Table 1 from An enhanced International Prognostic Index (NCCN-IPI) for  patients with diffuse large B-cell lymphoma treated in the rituximab era. |  Semantic Scholar
Table 1 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar

International prognostic indices in diffuse large B-cell lymphoma: a  comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect

international Prognostic index (iPi) for nHl | Download Table
international Prognostic index (iPi) for nHl | Download Table

IPI Definition: International Prognostic Index | Abbreviation Finder
IPI Definition: International Prognostic Index | Abbreviation Finder

A new prognostic score for AIDS-related lymphomas in the rituximab-era |  Haematologica
A new prognostic score for AIDS-related lymphomas in the rituximab-era | Haematologica

A new prognostic score for AIDS-related lymphomas in the rituximab-era |  Haematologica
A new prognostic score for AIDS-related lymphomas in the rituximab-era | Haematologica

Table 3 from An enhanced International Prognostic Index (NCCN-IPI) for  patients with diffuse large B-cell lymphoma treated in the rituximab era. |  Semantic Scholar
Table 3 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar

The revised International Prognostic Index (R-IPI) is a better predictor of  outcome than the standard IPI for patients with diffuse large B-cell  lymphoma. - ppt download
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma. - ppt download

MYC and BCL-2 adjusted-International Prognostic Index (A-IPI) is a better  predictor of outcome than the standard IPI for patients with diffuse large  B-cell lymphoma treated with R-CHOP. | Semantic Scholar
MYC and BCL-2 adjusted-International Prognostic Index (A-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. | Semantic Scholar

ASCO 2020 Top 12” #6: Cause of Death in Patients with Newly Diagnosed  Chronic Lymphocytic Leukemia (CLL) Stratified by the CLL-International Prognostic  Index (CLL-IPI) - CLL Society
ASCO 2020 Top 12” #6: Cause of Death in Patients with Newly Diagnosed Chronic Lymphocytic Leukemia (CLL) Stratified by the CLL-International Prognostic Index (CLL-IPI) - CLL Society

Table 1 from The revised International Prognostic Index (R-IPI) is a better  predictor of outcome than the standard IPI for patients with diffuse large  B-cell lymphoma treated with R-CHOP. | Semantic Scholar
Table 1 from The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. | Semantic Scholar

IPI - Index für Lymphome
IPI - Index für Lymphome

International Prognostic Index: Agressive Non-Hodgkin's Lymphoma
International Prognostic Index: Agressive Non-Hodgkin's Lymphoma

An international prognostic index for patients with chronic lymphocytic  leukaemia (CLL-IPI): a meta-analysis of individual patient data - The  Lancet Oncology
An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data - The Lancet Oncology

Prognostic indices and the risk stratification of IPI and NCCN-IPI. |  Download Table
Prognostic indices and the risk stratification of IPI and NCCN-IPI. | Download Table

IPI, 비호지킨 림프종, International Prognostic Index for Non-Hodgkin's Lymphoma :  네이버 블로그
IPI, 비호지킨 림프종, International Prognostic Index for Non-Hodgkin's Lymphoma : 네이버 블로그

Kyle Bradley, MD on Twitter: "New CLL International Prognostic Index.  Modern update to Rai and Binet staging systems. https://t.co/GRXAewz8FF  https://t.co/YrIrOG4Ym6" / Twitter
Kyle Bradley, MD on Twitter: "New CLL International Prognostic Index. Modern update to Rai and Binet staging systems. https://t.co/GRXAewz8FF https://t.co/YrIrOG4Ym6" / Twitter

Is NCCN-IPI a Better Prognostic Tool for DLBCL Treated With R-CHOP?
Is NCCN-IPI a Better Prognostic Tool for DLBCL Treated With R-CHOP?

Age-adjusted International Prognostic Factor Index (IPI) in 8-and... |  Download Table
Age-adjusted International Prognostic Factor Index (IPI) in 8-and... | Download Table

Validation of nomogram-revised risk index and comparison with other models  for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy  era: indication for prognostication and clinical decision-making | Leukemia
Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making | Leukemia

Reassessment of the prognostic value of the International Prognostic Index  and the revised International Prognostic Index in patients with diffuse  large B-cell lymphoma: A multicentre study
Reassessment of the prognostic value of the International Prognostic Index and the revised International Prognostic Index in patients with diffuse large B-cell lymphoma: A multicentre study